Abstract:Objective: To analyze the screening, diagnosis, epidemiology, pregnancy outcomes and treatment status in hepatitis C virus antibody-positive pregnant women, in order to provide clinical evidence for further improving prevention and control of maternal and infant safety. Methods: Data of 246 HCV antibody-positive pregnant women admitted to the Second Hospital of Nanjing from January 2014 to December 2019 were analyzed by epidemiological survey research method. Statistical analysis was performed according to different data using t-test, χ2 test, corrected χ2 test or Fisher's exact test. Results: 80 of 246 HCV antibody-positive women had confirmed infection before pregnancy. Of these, 85% were HCV RNA positive, and 16 became pregnant after antiviral therapy. Prenatal examination during pregnancy found that 166 cases were HCV RNA positive, and the HCV RNA positive rate was 81.93%. In the relationship between infection route and birth cohort in HCV antibody-positive pregnant women, there was a statistically significant differences in the proportions of transmission route among birth cohort (χ2=115.6, P＜0.001). With the delay of birth cohort, the proportion of infection through drug use was decreased (P＜0.001), while the proportion of acupuncture-associated infection (P=0.043) and infant hospitalization history were increased (P=0.005). Among pregnancy complications, HCV antibody-positive pregnant women in HCV RNA＜5.0 E+02 IU/ml and ≥5.0 E+02 IU/ml groups had intrahepatic cholestasis of pregnancy (χ2=4.73, P=0.030) and gestational hypertension (χ2=8.65, P=0.003), and the difference in incidence was statistically significant. Postpartum treatment strategy data analysis showed that the treatment rate was highest in the first year of postpartum, and then showed an upward trend year by year, with a statistically significant difference (χ2=17.26,P =0.004). Conclusion: Anti-HCV screening rates are lower among pregnant and reproductive age women. HCV screening should be used as an important supplementary means to strengthen maternal safety and health education management during pregnancy. Active postpartum antiviral therapy, with particularly emphasis on management within the first year after delivery, can significantly improve the treatment rate among women of child bearing age.

Relationship between viral load and pregnancy outcomes among hepatitis B carriers

Effect of Prophylactic Antiviral Intervention on T Cell Immunity in Hepatitis B Virus-Infected Pregnant Women

Outcomes of Assisted Reproductive Technology in Women Infected with the Hepatitis B Virus

Hepatitis B Virus in Oocytes and Embryos: Pregnancy Outcomes and Children’s Health

Comparison of HBV-DNA and HBeAg As Antiviral Therapeutic Indicators among HBV-infected Pregnant Women: a Systematic Review and Meta-Analysis

Association of gestational hepatitis B virus infection and antiviral therapy with pregnancy outcomes: A retrospective study

Maternal HBsAg carriers and adverse pregnancy outcomes: a hospital-based prospective cohort analysis.

Maternal hepatitis B virus carrier status and pregnancy outcomes: a prospective cohort study

[Correlation between hepatitis B virus infection and adverse pregnancy outcomes-a systematic review and meta-analysis]

Kinetic Changes of Viremia and Viral Antigens of Hepatitis B Virus During and after Pregnancy.

[Correlation Between Serum HBV DNA Level and HBsAg Titer in HBeAg-positive Pregnant Women and Impact of Genomic Variability of Hepatitis B Virus Pre S/S Regions on Their Correlations].

Comparison of Hepatitis B Viral Loads and Viral Antigen Levels in Child-Bearing Age Women with and Without Pregnancy

Chronic maternal hepatitis B virus infection and pregnancy outcome- a single center study in Kunming, China

Evaluating the relationship between hepatitis B viral activity and gestational diabetes mellitus: A prospective cohort study

Psychological stress; knowledge, attitude and practice and acceptance of antiviral therapy in pregnant women with hepatitis B in Zhejiang, China: a case comparison study

Analysis of the HBV Infection Status in HBsAg Positive Pregnant Women Prior to Their Delivery

Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome

Twin pregnancy outcomes of maternal hepatitis B virus carrier state

Impact of Maternal HIV–HBV Coinfection on Pregnancy Outcomes in an Underdeveloped Rural Area of Southwest China

[A Survey of the Current Status of Research on the Diagnosis and Treatment of Hepatitis C Virus Antibody-Positive Pregnant Women].

Hepatitis B surface antigen carrier status and its correlation to gestational hypertension